Using a self-reported functional score to assess disease progression in systemic sclerosis.
about
Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases.Digital ulcers and outcomes assessment in scleroderma.Treatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial.Functional disability and other health-related quality-of-life domains: points to consider for clinical trials in systemic sclerosis.Assessment of skin involvement in systemic sclerosis.A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis.
P2860
Using a self-reported functional score to assess disease progression in systemic sclerosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Using a self-reported function ...... ression in systemic sclerosis.
@en
type
label
Using a self-reported function ...... ression in systemic sclerosis.
@en
prefLabel
Using a self-reported function ...... ression in systemic sclerosis.
@en
P2093
P356
P1433
P1476
Using a self-reported function ...... ression in systemic sclerosis.
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/KEL432
P577
2007-04-10T00:00:00Z